If you like to start with a different book from a long-term dividend grower, you should discover this site: Dividend Champions Corporate Factbooks.
Walgreens Boots Alliance, Inc. (WBA) Company Profile:
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics. It also provides specialty pharmacy services and mail services; and manages in-store clinics. As of August 31, 2017, this segment operated 8,100 retail stores under the Walgreens and Duane Reade brands in the United States; and 7 specialty pharmacies, as well as approximately 400 in-store clinic locations. The Retail Pharmacy International segment sells prescription drugs; and health, beauty, toiletry, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,722 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 637 optical practices, including 178 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in France, the United Kingdom, Germany, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Price: 64,87 Mean Analyst Target Price: 80,96
Market cap.: 64.08Billion| Sector: Services | Industry: Drug Stores
Sales: 124.03Billion | Income: 4.32Billion
1-Year Price Range: 61.56 - 83.89 | 1-Y Performance: -21.7% | YTD Performance: -10.7%
Yield: 2.47% | P/E: 15,49 | Fwd. P/E 10 | P/S: 0,52 | P/B: 2,35
Key Ratios:
Growth
Sales Growth Q/Q
12.10%
|
EPS Growth
Q/Q
58.20%
|
EPS Growth This Year
-1.10%
|
EPS Growth Next Year
8.88%
|
EPS Growth Next 5
Years
11.82%
|
Sales Growth Past 5
Years
10.50%
|
EPS Growth Past 5
Years
9.40%
|
Returns, Margin and Leverage
Return on Assets
6.00%
|
Return on Equity
14.90%
|
Gross Margin
24.10%
|
ROI
11.90%
|
Operating Margin
4.60%
|
Profit Margin
3.30%
|
Debt-to-Equity Ratio
0,57
|
Per Share Data
Price
64,87
|
Analyst Target price
80,96
|
Cash per Share
1,77
|
Book Value Per share
27,6
|
EPS TTM
4,19
|
EPS Next Year
6,49
|
Dividend
Payout
38.60%
|
Valuation
P/E
15,49
|
Forward
P/E
10
|
Price to Sales
0,52
|
Price to Book
2,35
|
PEG
1,31
|
Beta
1,11
|
RSI
55,61
|
5-Year Stock Dividend Chart
10-Year Stock Return Heatmap
If you want to receive the full Corporate Factbook of Walgreens Boots Alliance, Inc. with all fresh updated content tables, just make a small donation of just 9 USD.
After we’ve received the donation, we will send you the full PDF to your donation e-mail address.
This update is created for you exclusively. If you like to join the lifetime e-mail list of the latest Corporate Factbook updates, just use the general link here. You can decide how much you like to support us.
Thank you so much for supporting us.
Here is an example of the fresh updated Corporate Factbook you will receive: